BioLineRx Receives Confirmation of Medical Device Classification in Europe for Celiac Treatment

BL-7010 receives designation as Class IIb medical device

TEL AVIV, Israel, January 25, 2016 -- (Healthcare Sales & Marketing Network) -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensi... Biopharmaceuticals, Devices, RegulatoryBioLineRx, Celiac disease, BL-7010

Source: HSMN NewsFeed - January 25, 2016 Category: Pharmaceuticals Source Type: news